Alyeska Investment Group, L.P. Profound Medical Corp. Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Profound Medical Corp. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 160,000 shares of PROF stock, worth $926,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,000
Previous 160,000
-0.0%
Holding current value
$926,400
Previous $931,000
1.4%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PROF
# of Institutions
46Shares Held
12.6MCall Options Held
0Put Options Held
0-
Fil LTD Hamilton, D01.89MShares$10.9 Million0.01% of portfolio
-
Gagnon Securities LLC1.75MShares$10.1 Million2.22% of portfolio
-
Letko, Brosseau & Associates Inc Montreal, A81.2MShares$6.97 Million0.14% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL942KShares$5.45 Million0.0% of portfolio
-
Gagnon Advisors, LLC897KShares$5.19 Million3.86% of portfolio
About Profound Medical Corp.
- Ticker PROF
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,851,300
- Market Cap $121M
- Description
- Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...